Skip to main content
Hao Zhu, MD, Oncology, Dallas, TX

Hao Zhu MD

Oncology•Dallas, TX

Instructor in Medicine, Dana-Farber Cancer Institute

Join to View Full Profile

  • 5323 Harry Hines BoulevardDallas, TX 75390

  • Phone+1 214-648-2395

  • Fax+1 214-648-3088

Dr. Zhu is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.
See Dr. Zhu's Full ProfileAlready have an account?

Education & Training

  • Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer Institute
    Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2007 - 2011
  • University of California (San Francisco)
    University of California (San Francisco)Residency, Internal Medicine, 2005 - 2007
  • Harvard Medical School
    Harvard Medical SchoolClass of 2005

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 2012 - 2025
  • MA State Medical License
    MA State Medical License Active through 2013
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Press Mentions

  • UTSW Research: COVID-19’s Effects, Brain-Computer Interfaces, and More
    UTSW Research: COVID-19’s Effects, Brain-Computer Interfaces, and MoreJanuary 22nd, 2025
  • Children’s Research Institute at UT Southwestern Identifies Metabolic Inflexibility That Keeps Damage at Bay During Liver Regeneration
    Children’s Research Institute at UT Southwestern Identifies Metabolic Inflexibility That Keeps Damage at Bay During Liver RegenerationJuly 25th, 2024
  • The Current Issue of “The View from Here” Is Concerned with Artificial Intelligence
    The Current Issue of “The View from Here” Is Concerned with Artificial IntelligenceApril 20th, 2021
  • Join now to see all

Grant Support

  • Elucidating chronic liver disease pathways using somatic geneticsUT SOUTHWESTERN MEDICAL CENTER2024–2029
  • Elucidating chronic liver disease pathways using somatic geneticsUT SOUTHWESTERN MEDICAL CENTER2024–2029
  • Elucidating chronic liver disease pathways using somatic geneticsUT SOUTHWESTERN MEDICAL CENTER2024–2029
  • Elucidating chronic liver disease pathways using somatic geneticsUT SOUTHWESTERN MEDICAL CENTER2024–2029
  • Elucidating chronic liver disease pathways using somatic geneticsUT SOUTHWESTERN MEDICAL CENTER2024–2029
  • Integrated Transporter Elucidation CenterRUTGERS BIOMEDICAL AND HEALTH SCIENCES2023–2028
  • Diversity Supplement to Integrated Transporter Elucidation CenterRUTGERS BIOMEDICAL AND HEALTH SCIENCES2023–2028
  • Diversity Supplement to Integrated Transporter Elucidation CenterRUTGERS BIOMEDICAL AND HEALTH SCIENCES2023–2028
  • Diversity Supplement to Integrated Transporter Elucidation CenterRUTGERS BIOMEDICAL AND HEALTH SCIENCES2023–2028
  • Integrated Transporter Elucidation CenterRUTGERS BIOMEDICAL AND HEALTH SCIENCES2023–2028
  • Diversity Supplement to Integrated Transporter Elucidation CenterRUTGERS BIOMEDICAL AND HEALTH SCIENCES2023–2028
  • Diversity Supplement to Integrated Transporter Elucidation CenterRUTGERS BIOMEDICAL AND HEALTH SCIENCES2023–2028
  • Diversity Supplement to Integrated Transporter Elucidation CenterRUTGERS BIOMEDICAL AND HEALTH SCIENCES2023–2028
  • Diversity Supplement to Integrated Transporter Elucidation CenterRUTGERS BIOMEDICAL AND HEALTH SCIENCES2023–2028
  • Integrated Transporter Elucidation CenterRUTGERS BIOMEDICAL AND HEALTH SCIENCES2023–2028
  • Virtual nanostructure simulation (VINAS) portalTULANE UNIVERSITY OF LOUISIANA2023–2027
  • Determining how chronic ETOH influences the regenerative activities of hepatocyte subpopulationsUT SOUTHWESTERN MEDICAL CENTER2021–2026
  • Mechanism-Driven Virtual Adverse Outcome Pathway Modeling for HepatotoxicityTULANE UNIVERSITY OF LOUISIANA2023–2025
  • Improving hepatocellular carcinoma mouse modeling by understanding the malignant potential and biology of liver cell subpopulationsUT SOUTHWESTERN MEDICAL CENTER2020–2025

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence:

Dr. Hao Zhu, Dr. Hao Zhu, MD, Dr. H Zhu